Search - tctmd.com

Displaying 41 - 60 of 285

Sort: Relevancy | Date

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

News Conference News CRT 2019

ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice

Yael L. Maxwell

March 07, 2019

News Daily News

Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI

Todd Neale

January 04, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Conference News AHA 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

Shelley Wood

November 13, 2018

News Opinion Off Script TCT 2018

Off Script: Phantom Hearts and the Elusive Nature of Angina

Kwan S. Lee

October 11, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits

September 25, 2018

Presentation TCT 2018

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Presenter: Felix Mahfoud, Patrick W. Serruys, Gregg W. Stone

September 25, 2018

Presentation TCT 2018

Falcon Development and Status

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Richard J. Rapoza

September 22, 2018

Presentation TCT 2018

How to Improve BRS Outcomes: Focus on Imaging and Technique

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Ziad A. Ali

September 22, 2018

Presentation TCT 2018

How to Improve BRS Outcomes: Focus on the Device

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Yoshinobu Onuma

September 22, 2018

Presentation TCT 2018

ABSORB 4-Year Meta-Analysis: Individual Patient-Data Analysis

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Gregg W. Stone

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB III 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Dean J. Kereiakes

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB China 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Runlin Gao

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB Japan 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Kengo Tanabe

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB II 5-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Patrick W. Serruys

September 22, 2018

Presentation TCT 2018

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Antonio L. Bartorelli, David G. Rizik, Michael Haude

September 21, 2018

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes

September 21, 2018

Advertisement

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice

Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI

Top News in Coronary Artery Disease: 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

Off Script: Phantom Hearts and the Elusive Nature of Angina

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Falcon Development and Status

How to Improve BRS Outcomes: Focus on Imaging and Technique

How to Improve BRS Outcomes: Focus on the Device

ABSORB 4-Year Meta-Analysis: Individual Patient-Data Analysis

ABSORB Beyond 3 Years: ABSORB III 4-Year Data

ABSORB Beyond 3 Years: ABSORB China 4-Year Data

ABSORB Beyond 3 Years: ABSORB Japan 4-Year Data

ABSORB Beyond 3 Years: ABSORB II 5-Year Data

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content